Form 8-K - Current report:
SEC Accession No. 0001104659-21-134705
Filing Date
2021-11-05
Accepted
2021-11-05 06:40:52
Documents
15
Period of Report
2021-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131993d1_8k.htm   iXBRL 8-K 30164
2 EXHIBIT 99.1 tm2131993d1_ex99-1.htm EX-99.1 326059
7 GRAPHIC tm2131993d1_ex99-1sp01img002.jpg GRAPHIC 8580
  Complete submission text file 0001104659-21-134705.txt   624093

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elan-20211105.xsd EX-101.SCH 3901
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20211105_def.xml EX-101.DEF 27335
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20211105_lab.xml EX-101.LAB 37974
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20211105_pre.xml EX-101.PRE 25947
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2131993d1_8k_htm.xml XML 5162
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 211382243
SIC: 2834 Pharmaceutical Preparations